Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.
LATEST PROSTATE CANCER CONTENT
Understanding the Sequencing Decisions in mCRPC After Progression on ADT/ARPI
Availability, Tolerability, and Drug Interactions Drive ARPI Selection in mHSPC
Evaluating Radium-223 Combinations and Bone Protection in mCRPC
Exploring Treatment Strategies in High-Volume mHSPC
Evolving Standard of Care for mHSPC Prompts Interest in Deescalation
CBR Polling Shows Rapid Uptake of Darolutamide in mHSPC
Disease Factors Can Support Intensification or Deescalation in HSPC
Rates of Drug Interactions Differentiate ARPIs for Treating mHSPC
CASE-BASED ROUNDTABLES
Advertisement
Advertisement